Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x

Foren & Soziale Netzwerke zur HIMS & HERS Aktie

 >HIMS & HERS Aktienkurs 
39.79 EUR    -2.5%    (Tradegate)
Ask: 39.99 EUR / 500 Stück
Bid: 39.2 EUR / 800 Stück
Tagesumsatz: 35881 Stück
Realtime Kurs von 8 bis 22 Uhr!
HIMS & HERS Aktie über LYNX handeln
>HIMS & HERS Performance
1 Woche: -6,2%
1 Monat: -15,5%
3 Monate: +67,3%
6 Monate: +54,3%
1 Jahr: +112,3%
laufendes Jahr: +58,8%
>HIMS & HERS Aktie
Name:  HIMS & HERS HEALTH INC.
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US4330001060 / A2QMYY
Symbol/ Ticker:  82W (Frankfurt) / HIMS (NYSE)
Kürzel:  FRA:82W, ETR:82W, 82W:GR, NYSE:HIMS
Index:  -
Webseite:  https://www.hims.com/
Marktkapitalisierung:  10710 Mio. EUR
Umsatz:  1541.11 Mio. EUR
EBITDA:  119.2 Mio. EUR
Gewinn je Aktie:  0.502 EUR
Schulden:  54.87 Mio. EUR
Liquide Mittel:  279.37 Mio. EUR
Umsatz-/ Gewinnwachstum:  110.7% / 344.7%
KGV/ KGV lG:  81.74 / 91.74
KUV/ KBV/ PEG:  7.51 / 22.65 / 5.16
Gewinnm./ Eigenkapitalr.:  9.21% / 36.79%
Dividende je Aktie:  -
Dividendenrendite/ -schätzung:  - / -
Insiderhandel:  5 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 17.940.162 USD.
Suchwörter:  HIMS & HERS, HIMS AND HERS, HIMS HERS
Letzte Datenerhebung:  06.07.25
>HIMS & HERS Eigentümer
Aktien: 215.45 Mio. St.
f.h. Aktien: 194.66 Mio. St.
Insider Eigner: 11.09%
Instit. Eigner: 74.38%
>HIMS & HERS Peer Group

HCA
 
25.06.25 - 18:00
6/25/25 - $hims - How I'm trading this for size (TradingView)
 
6/25/25 :: VROCKSTAR :: NYSE:HIMS How I'm trading this for size - i make a lot of moves, as you can tell. but you'll also notice i tend to find positions that i like as i validate the thesis... and go massive - NYSE:HIMS and NASDAQ:TSLA are two names that i'm not new to, but have been wrangling for some time given valuations really haven't been "cheap" per se. there's a good reason for that. - so $hims. i reset book last night, and now after seeing this thing to red on the day after opening to a squeeze nearly >5%... i'm back to wranging. i. want. to. own. this. it's scarce paper. a scarce CEO. scarce growth. and it's hitting right at the heart of the war on pharma, in it's own "novel" way that just makes me excited to root for the success. - valuation is not honestly, expensive - but communication and headlines will drive a lot of price action (as has been the case) now that NVO has unofficially announced that they're losing market share and, frankly, the stock is uninvestable and will ultimately u
23.06.25 - 19:09
6/23/25 - $hims - Time to re-accumulate (TradingView)
 
6/23/25 :: VROCKSTAR :: NYSE:HIMS Time to re-accumulate - NYSE:NVO are playing dirty and this is a tell and low-key admission that NYSE:HIMS holds all the power - distribution is key... look at NASDAQ:META , NASDAQ:AAPL , $AMZN. he who holds the customer relationship makes the rules - there is no longer a major advantage in developing pharma, the majority of solutions can now roll off patents and/or be compounded *legally* - so what you're seeing here is cartel-like behavior from a slow motion train wreck NYSE:NVO - which i've liked the past - but ultimately the stock will lose to names like NYSE:HIMS (and other pharma too). - so will they get sued? who tf cares. we'll buy more - this is a rule of 40 winner, even if law suit is large, it won't affect the story and growth. and major kudos to Andrew (the rockstar CEO) that put out this tweet. this is a founder-leader you want to put your portfolio behind when the opportunities arise. i'll be looking for oppty in the coming days/weeks to own more o
10.06.25 - 22:39
$HIMS setting up for its next big move—here's what I'm watching! (TradingView)
 
? NYSE:HIMS setting up for its next big move—here's what I'm watching! ? ? Eyeing momentum down to $44-$48, and I'm not mad about it! ? That flip from resistance to support is key for long-term price growth. ? Bull flag breakout could come sooner—stay locked in! Keeping an eye on it all for the next trade entry on this beast! ? What's your take? Are we bouncing or breaking out? Drop your thoughts below! ⬇️
09.06.25 - 18:18
HIMS – Long Setup | Potential 60% Move (TradingView)
 
Hims & Hers (HIMS) just gave us a textbook Ichimoku breakout and is holding strong above the cloud after a healthy pullback. Technical Breakdown: Price above Kumo Cloud: Bullish structure intact. Support held at $54.62 – key base above cloud and Tenkan-sen. MACD is curling back after a corrective wave, showing early signs of momentum returning. Risk/Reward: 8.59 – Extremely favorable. Target: $93.58 (60.22% upside) Stop: $51.78 (7.01% downside) Rationale: HIMS continues to ride bullish sentiment in the healthcare and telemedicine sectors. This chart has a clean continuation setup with institutional buy zones likely around $54-$55. Risk is tightly controlled, and upside potential is significant.
15.05.25 - 16:33
HIMS – Pullback Opportunity After Massive Run (TradingView)
 
HIMS has been one of the hottest stocks in the market recently, with a massive run fueled by strong earnings. But now we're seeing the first meaningful pullback — and this could be a golden opportunity: ? Earnings Gap Reversal (Bullish Signal) Despite an earnings gap down, buyers stepped in aggressively, pushing the stock higher. This is a classic earnings gap down reversal — a strong sign of demand. ? First Pullback Opportunity Historically, the first pullback after a major run tends to get bought. I'm watching two key levels for a potential buy: The shaded zone between the 9 EMA and 20 EMA (dynamic support). The 0.38 - 0.50 Fibonacci retracement for added confirmation. ? My Trading Plan: 1️⃣ Initial Entry: Starter position in the shaded EMA zone (9 EMA - 20 EMA). 2️⃣ Confirmation Add: If price bounces off the Fib zone (0.38 - 0.50) with strength. 3️⃣ Stop Loss: Below the 20 EMA for any initial position — keeping risk tight. ? Why This Setup is Compelling: Strong run + earnings reversal shows real
11.05.25 - 22:54
BiotechBee: buy Hims & Hers Health Inc. (Sharewise)
 
Kursziel: 100.0 €
11.05.25 - 21:51
HIMS: More Upside IMO but let's Review All Scenarios (TradingView)
 
Bullish Scenario If HIMS continues higher, we may see a shallow pullback first, possibly around 46.75, which lines up with one of my key levels and the uptrend line drawn from late April. A slightly deeper dip into the 10EMA would also be a healthy reset. From there, a move back through last week's high and a continuation up along the uptrend line would confirm strength and keep this breakout intact. If momentum holds, I'm watching for a move toward 65, which sits just below the all-time high. This area could act as resistance, gearing up to establish a new ATH. If we get a new ATH, I'd could see the momentum gain to the upside from the excitement, then an immediate period of digestion, either sideways or a decline as buyers take profits. Neutral Scenario A sideways range around the current zone would be healthy digestion after the recent run. This could look like price holding between the retest levels (roughly 52–56), bouncing in a tight range as momentum resets. In this c
06.05.25 - 15:03
Needham___Company_LL: buy Hims & Hers Health Inc. (Sharewise)
 
Kursziel: 54.0094 €
05.05.25 - 22:48
$HIMS is HIMS! 80% Upside Ahead (TradingView)
 
NYSE:HIMS is HIMS! 80% Upside Ahead Demolished earnings and I have this name at a fair value of $76 per share based on HIMS 2030 $6.5B Rev. Guidance. Also, H5_L Indicator is about to cross bullish while the Wr% is rising and swinging from green to red! Profit Targets: - $50 - $60 - ATHs! Before EOY! Not financial Advice
03.05.25 - 22:15
melinda: buy Hims & Hers Health Inc. (Sharewise)
 
Kursziel: 60.0 €
29.04.25 - 18:48
Bank_of_America_Co_: sell Hims & Hers Health Inc. (Sharewise)
 
Kursziel: 22.828 €
28.04.25 - 00:00
HIMS: how I charted this + bullish/bearish/neutral scenarios! (TradingView)
 
Bullish A break and hold above the 20EMA would shift momentum back to the upside. Initial resistance would be around 30, where previous price congestion sits. If buyers can push through, next target would be around 35–36, near the declining 50SMA. There is a short-term intraday trendline forming on the hourly chart that could act as a support guide if the stock starts climbing. Bearish A rejection from the downtrend line or failure to hold above the 20EMA could lead to a move lower. Breaking below the 24–25 support area would be a key bearish trigger. If that level fails, the next major downside target would be near 19.5. Neutral Continued sideways chop around the moving averages.
25.04.25 - 17:03
Citigroup_Inc_: sell Hims & Hers Health Inc. (Sharewise)
 
Kursziel: 22.035 €
24.03.25 - 17:27
geldnutzer: buy Hims & Hers Health Inc. (Sharewise)
 
Kursziel: 39.0 €
08.03.25 - 19:51
Where is $HIMS going next? Massive upside (TradingView)
 
Where is NYSE:HIMS going next? Massive upside Watch now to find out! Not financial advice
07.03.25 - 17:06
HIMS: we may revisit 30s... (TradingView)
 
Bullish about the business, but the chart is really an ugly one.
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Männer sind wie Luft, zwar versaut, aber unentbehrlich. - Michelle Pfeiffer
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!